Title of activity: Assessing and Managing IBS-C

• Jointly provided by Partners for Advancing Clinical Education (PACE) and Tuesday Night IBS
• This activity is supported by an independent educational grant from Ardelyx
• Estimated time to complete the activity: 4 hours
• For additional information about the accreditation of this activity, please visit https://partnersed.com

Target Audience

This activity is intended for gastroenterologists and advance practice providers who work in gastroenterology clinics and academic medical centers as well as primary care physicians who also frequently see and treat patients with IBS-C.

Educational Objectives                                                   

Upon completion of this activity, participants should be able to:

• Assess patients with symptoms suggestive of IBS‐C and make a clear diagnosis, using the Rome IV criteria and limited diagnostic testing, as needed.
• Select individualized treatment(s) for patients with IBS‐C, including the latest novel therapies to treat IBS-C
• Use evidence‐based approaches for the management of IBS‐C including understanding the role of dietary therapy, behavioral health and CAM therapies.
• Communicate more effectively with their patients to understand the symptoms, the burden of illness and impact of QOL. They will be able to use shared decision making in a patient-centered care model to effectively manage their patients with IBS-C. 

Faculty and Disclosure of Conflicts of Interest

PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:

The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Tuesday Night IBS.  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education
PACE designates this other activity, Gather-ed, for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 4.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

Psychologist Continuing Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

Credit Designation

This program offers 4.0 continuing education credits for psychologists.
 

Dietitian Continuing Education
This program offers 4.0 CPEUs for dietitians.
 

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
 

Instructions for Credit

Participation in this activity should be completed in approximately 4 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from through :

Read the target audience, learning objectives, and faculty disclosures.
Study the educational activity.
To claim the maximum amount of credit available, you must complete all of the following:

• Completion of baseline assessment: 0.25 credit hour
• Completion of four self-study modules: 0.25 credit hour per module, for a total of 1.0 credit hour
• Live Group Discussion 1: 0.5 credit hour
• Live Group Discussion 2: 0.5 credit hour
• Completion of group challenges (3): 0.5 credit hour per challenge, for a total of 1.50 credit hours
• Completion of final assessment: 0.25 credit hours